Duane Nash Insider Profile
4 Followers
Duane Nash, EC, Director at Immunic, holds 36.03K shares in Immunic (Ticker: IMUX), holds 21.50K shares in Akebia Therapeutics (Ticker: AKBA). Most recently, Duane Nash Bought ― shares of Immunic on Jun 16, 2025 for an estimated value of $16.60K.
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-20.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Duane Nash holds in companies
Most Profitable Insider Trade
The most profitable trade made by Duane Nash
Duane Nash's Trading History
Immunic
Jun 16, 2025
EC, Director
Informative Buy
16.60K
$459.77K
Akebia Therapeutics
Feb 16, 2018
Director
Uninformative Sell
14.62K
$21.13K
List of latest transactions for each holding click on a transaction to see Duane Nash's performance on stock
You May Also Like
Duane Nash insider profile FAQ
What is the percentage of profitable transactions made by Duane Nash?
The percentage of profitable transactions made by Duane Nash is 33%.
What is the average return per transaction made by Duane Nash?
The average return per transaction made by Duane Nash is -20.80%.
What stocks does Duane Nash hold?
Duane Nash holds: IMUX, AKBA stocks.
What was Duane Nash’s latest transaction?
Duane Nash latest transaction was an Informative Buy of $16.60K.
What was Duane Nash's most profitable transaction?
Duane Nash’s most profitable transaction was an Informative Buy of IMUX stock on June 16, 2025. The return on the trade was 67.00%.
What is Duane Nash's role in Immunic?
Duane Nash's role in Immunic is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.